Preventive Care

Less than 16% of high-risk lung cancer individuals have heard or discussed lung cancer screenings with a health care provider.

Despite the new human case, which is not known to be related to animal exposure, the CDC emphasizes that risk to the general public remains low.

The researchers found that unusual and dramatic changes in weather as well as heavy rainfall helped aid in the pathogen’s evolutionary change.

The study may serve as a foundation for future investigation regarding dietary recommendations to support the treatment of Alzheimer disease.

The CDC says that even if travel is less than 2 weeks away, unvaccinated individuals should still receive a dose of the measles, mumps, and rubella vaccine for protection against the disease.

Study shows that orange peel extract may reduce risk of heart disease and adverse cardiovascular events.

The 5-in-1 meningococcal ABCWY vaccine candidate has an assigned Prescription Drug User Fee Act action date of February 14, 2025.

Children with normal weight had different community relationships compared to children with overweight or obesity.

Individuals that lived on a majority plant-based or vegetarian/vegan diet were 39% less likely to be infected with COVID-19.

mRNA-1083 is an investigational combination vaccine designed to prevent influenza and COVID-19.

The study results also indicate no significant difference of venous thromboembolism risk between individuals with immune-mediated inflammatory diseases and individuals without.

An upcoming large-scale clinical trial of the Glucose Everyday Matters program will evaluate its safety and efficacy in managing type 2 diabetes.

Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.

Compared to the BNT162b2 vaccine, the mRNA-1273 vaccine was associated with a lower risk of adverse events, which investigators speculate was due to interrelated safety and efficacy.

If approved, the V116 vaccine would be the first pneumococcal conjugate vaccine specifically designed for adults.

Further research is necessary in order to investigate whether poor sleep can be a potential risk factor for dementia.

Investigators urge policymakers to establish flexible models that maximize coverage when respiratory syncytial virus activity is high and minimize unnecessary doses when viral activity is low.

Multivitamins were associated with increased cellular oxygen consumption and more optimal blood nutrition biomarkers.

The CDC has recommended a follow-up nucleic acid amplification test to be used for patients clinically suspected to have influenza, despite a negative POC test.

Reporting vaccination data to Immunization Information Systems databases can support public health surveillance activities.

Agency updates emergency use authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccinations, which are no longer authorized for used in the United States.

Findings from the ongoing Adult Respiratory Syncytial Virus phase 3 trial suggest RSVPreF3 OA vaccine is effective and safe for individuals aged 60 years and older.

Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.

US adults have a slightly stronger preference for fewer adverse events in relation to pediatric COVID-19 vaccination, study results show.

The number of Mpox cases is expected to rise, which requires ongoing testing, vaccinations, and medication services by health care providers.

Booster shots updated for the Omicron variant BA.4 and BA.5 lineages cleared for children 6 months through 4 years of age.

The study could potentially lead to recommendations of higher vitamin D intake as a colorectal cancer prevention strategy for adults under 50 years of age.

The investigators examined data from more than 50,000 individuals participating in the Danish Diet, Cancer, and Health study over a 23-year period.

Both strains of Influenza A will be different from those included the northern hemisphere's last season.

The CDC considers individuals in the United States to be fully vaccinated 2 weeks after receiving a complete series of COVID-19 vaccine doses.